China conditionally approves Linde/Praxair merger
China’s competition authority will allow Linde’s proposed $83 billion merger with Praxair based on structural and behavioural remedies, leaving the US and Korea as the last major jurisdictions yet to clear the deal.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10